Y. Fujita

发表

Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates.

I. Toth, Y. Fujita, A. M. Abdel-Aal, 2008, Bioorganic & medicinal chemistry.

Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2.

I. Toth, Y. Fujita, A. M. Abdel-Aal, 2010, Vaccine.

Regenerative medicine legislation in Japan for fast provision of cell therapy products

Y. Fujita, A. Kawamoto, Y Fujita, 2016, Clinical pharmacology and therapeutics.

Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus.

I. Toth, Y. Fujita, M. Batzloff, 2008, Biopolymers.

Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia.

S. Salvadori, Y. Fujita, Y. Tsuda, 2003, Journal of medicinal chemistry.

Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3).

Y. Fujita, Y. Tsuda, Y. Okada, 2005, Bioorganic & medicinal chemistry letters.

Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond.

Y. Fujita, Y. Tsuda, Y. Okada, 2003, Bioorganic & medicinal chemistry.

Characterization of Toll-like Receptor 7 / 8 Agonist Amino Acid for Antigen-Adjuvant Conjugation Co-delivery System

Ryota Uchida, K. Nishida, Y. Fujita, 2019 .

Vaccination with Lipid Core Peptides Fails to Induce Epitope-Specific T Cell Responses but Confers Non-Specific Protective Immunity in a Malaria Model

D. Doolan, M. Skwarczynski, I. Toth, 2012, PloS one.

Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1

Y. Fujita, Y. Tsuda, Y. Okada, 2006, Pharmacology Biochemistry and Behavior.

Recent Advances in Design and Synthesis of Self-Adjuvanting Lipopeptide Vaccines

I. Toth, Y. Fujita, P. Simerská, 2008, International Journal of Peptide Research and Therapeutics.

A new pyrethroid of high insecticidal activity

Y. Fujita, M. Hirano, N. Itaya, 1981 .

Development of Potent Bifunctional Endomorphin-2 Analogues with Mixed μ-/δ-Opioid Agonist and δ-Opioid Antagonist Properties

Y. Fujita, Y. Tsuda, Y. Okada, 2004 .

Studies on the mechanism of 1,2-dihydropyrazin-2-one ring formation from dipeptidyl chloromethyl ketone and its chemical properties: immediate deamination during catalytic hydrogenation.

Y. Fujita, Y. Tsuda, Y. Okada, 2005, Chemical & pharmaceutical bulletin.

Immediate deamination from the aminomethyl group attached to 1,2-dihydropyrazin-2-one derivative during catalytic hydrogenation

Y. Fujita, Y. Tsuda, Y. Okada, 2002 .

Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.

Y. Fujita, Y. Tsuda, Y. Okada, 2005, European journal of pharmacology.

Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles

Y. Fujita, H. Taguchi, 2011, Chemistry Central journal.

Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines.

Mei-Fong Ho, Manisha Pandey, A. Suhrbier, 2007, Journal of medicinal chemistry.

Nanoparticle-Based Peptide Vaccines

Y. Fujita, H. Taguchi, 2016, Micro and Nanotechnology in Vaccine Development.

Overview and outlook of Toll-like receptor ligand-antigen conjugate vaccines.

Y. Fujita, H. Taguchi, 2012, Therapeutic delivery.

Mechanism of reactive oxygen species generation and oxidative DNA damage induced by acrylohydroxamic acid, a putative metabolite of acrylamide.

Y. Fujita, S. Oikawa, S. Kawanishi, 2021, Mutation research. Genetic toxicology and environmental mutagenesis.

A new pyrethroid-type ester with strong knockdown activity

Y. Fujita, H. Yoshioka, M. Hirano, 1979 .

Efficacy of the pyrethroid compound possessing a new type of alcohol moiety

Y. Fujita, S. Kitamura, M. Hirano, 1978 .

The Structure-Activity Relationship of Dmt-NH-X

Y. Fujita, Y. Tsuda, Y. Okada, 2004 .

6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccine

K. Nishida, Y. Fujita, H. Taguchi, 2016, Amino Acids.

Design and Synthesis of Lipopeptide–Carbohydrate Assembled Multivalent Vaccine Candidates Using Native Chemical Ligation

M. Skwarczynski, I. Toth, Y. Fujita, 2009 .

Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.

I. Toth, P. Moyle, Y. Fujita, 2008, Journal of medicinal chemistry.

Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.

I. Toth, P. Moyle, Y. Fujita, 2008, Journal of medicinal chemistry.

Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.

I. Toth, Y. Fujita, A. M. Abdel-Aal, 2010, Journal of medicinal chemistry.

Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.

I. Toth, Y. Fujita, M. Batzloff, 2012, Journal of medicinal chemistry.

Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship

I. Toth, Y. Fujita, A. M. Abdel-Aal, 2012, PloS one.

New series of potent δ-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motif

Y. Fujita, Y. Tsuda, Y. Okada, 2005 .

Combination of syringaresinol–di–O–β-d-glucoside and chlorogenic acid shows behavioral pharmacological anxiolytic activity and activation of hippocampal BDNF–TrkB signaling

Masato Ogata, H. Soya, T. Fujikawa, 2020, Scientific Reports.

Investigation toward multi-epitope vaccine candidates using native chemical ligation.

I. Toth, P. Moyle, Y. Fujita, 2008, Biopolymers.

Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties.

Y. Fujita, Y. Tsuda, Y. Okada, 2004, Journal of medicinal chemistry.

Identification of the minimal region of peptide derived from ADP‐ribosylation factor1 (ARF1) that inhibits IgE‐mediated mast cell activation

Ryota Uchida, K. Nishida, Y. Fujita, 2019, Molecular immunology.

Development of an activity-based probe for amyloid β-hydrolyzing antibodies.

Y. Fujita, Y. Tsuda, H. Taguchi, 2016, Bioorganic & medicinal chemistry letters.

Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2.

Y. Fujita, Y. Tsuda, Y. Okada, 2005, Journal of medicinal chemistry.

The insecticidal activity and the vapor pressure of the pyrethroids containing acyclic alcohol moieties

Y. Fujita, T. Yano, N. Matsuo, 1983 .

Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesia.

Y. Fujita, Y. Tsuda, Y. Okada, 2004, Journal of medicinal chemistry.

Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.

I. Toth, Y. Fujita, M. Batzloff, 2012, Journal of medicinal chemistry.